Drugs commonly associated with weight change: a systematic review and meta-analysis

JP Domecq, G Prutsky, A Leppin… - The Journal of …, 2015 - academic.oup.com
Context: Various drugs affect body weight as a side effect. Objective: We conducted this
systematic review and meta-analysis to summarize the evidence about commonly …

The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults

MJ Franz, MA Powers, C Leontos… - Journal of the American …, 2010 - Elsevier
This article reviews the evidence and nutrition practice recommendations from the American
Dietetic Association's nutrition practice guidelines for type 1 and type 2 diabetes in adults …

American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with …

WT Garvey, JI Mechanick, EM Brett, AJ Garber… - Endocrine Practice, 2016 - Elsevier
Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

AGA clinical practice guideline on pharmacological interventions for adults with obesity

E Grunvald, R Shah, R Hernaez, AK Chandar… - Gastroenterology, 2022 - Elsevier
Background & Aims Pharmacological management of obesity improves outcomes and
decreases the risk of obesity-related complications. This American Gastroenterological …

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER …

KM Gadde, DB Allison, DH Ryan, CA Peterson… - The Lancet, 2011 - thelancet.com
Background Obesity is associated with a reduction in life expectancy and an increase in
mortality from cardiovascular diseases, cancer, and other causes. We therefore assessed …

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease

JT Dudley, M Sirota, M Shenoy, RK Pai… - Science translational …, 2011 - science.org
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal
tract for which there are few safe and effective therapeutic options for long-term treatment …

Obesity and chronic kidney disease

Z Jiang, Y Wang, X Zhao, H Cui… - American Journal …, 2023 - journals.physiology.org
The prevalence of obesity has increased dramatically during the past decades, which has
been a major health problem. Since 1975, the number of people with obesity worldwide has …

Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes

A Gummesson, E Nyman, M Knutsson… - Diabetes, Obesity and …, 2017 - Wiley Online Library
Aim To quantify the effect of weight loss on glycated haemoglobin (HbA1c) at group level,
based on data from published weight loss trials in overweight and obese patients with type 2 …

Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes

AJ Scheen, LF Van Gaal - The lancet Diabetes & endocrinology, 2014 - thelancet.com
The increasing prevalence of obesity is contributing substantially to the ongoing epidemic of
type 2 diabetes. Abdominal adiposity, a feature of ectopic fat syndrome, is associated with …

Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind randomized controlled trial

V Vuksan, AL Jenkins, C Brissette, L Choleva… - Nutrition, Metabolism …, 2017 - Elsevier
Abstract Background and Aim Preliminary findings indicate that consumption of Salba-chia
(Salvia hispanica L.), an ancient seed, improves management of type 2 diabetes and …